Human Cardiovascular Physiology Laboratory, Department of Health and Exercise Science, Colorado State University, Fort Collins, Colorado.
Medical Center of the Rockies Foundation, University of Colorado Health, Loveland, Colorado.
J Appl Physiol (1985). 2021 Aug 1;131(2):566-574. doi: 10.1152/japplphysiol.00205.2021. Epub 2021 Jun 24.
The vascular endothelium senses and integrates numerous inputs to regulate vascular tone. Recent evidence reveals complex signal processing within the endothelium, yet little is known about how endothelium-dependent stimuli interact to regulate blood flow. We tested the hypothesis that combined stimulation of the endothelium with adenosine triphosphate (ATP) and acetylcholine (ACh) elicits greater vasodilation and attenuates α-adrenergic vasoconstriction compared with combination of ATP or ACh with the endothelium-independent dilator sodium nitroprusside (SNP). We assessed forearm vascular conductance (FVC) in young adults (6 women, 7 men) during local intra-arterial infusion of ATP, ACh, or SNP alone and in the following combinations: ATP + ACh, SNP + ACh, and ATP + SNP, wherein the second dilator was coinfused after attaining steady state with the first dilator. By design, each dilator evoked a similar response when infused separately (ΔFVC, ATP: 48 ± 4; ACh: 57 ± 6; SNP: 53 ± 6 mL·min·100 mmHg; ≥ 0.62). Combined infusion of the endothelium-dependent dilators evoked greater vasodilation than combination of either dilator with SNP (ΔFVC from first dilator, ATP + ACh: 45 ± 9 vs. SNP + ACh: 18 ± 7 and ATP + SNP: 26 ± 4 mL·min·100 mmHg, < 0.05). Phenylephrine was subsequently infused to evaluate α-adrenergic vasoconstriction. Phenylephrine elicited less vasoconstriction during infusion of ATP or ACh versus SNP (ΔFVC, -25 ± 3 and -29 ± 4 vs. -48 ± 3%; < 0.05). The vasoconstrictor response to phenylephrine was further diminished during combined infusion of ATP + ACh (-13 ± 3%; < 0.05 vs. ATP or ACh alone) and was less than that observed when either dilator was combined with SNP (SNP + ACh: -26 ± 3%; ATP + SNP: -31 ± 4%; both < 0.05 vs. ATP + ACh). We conclude that endothelium-dependent agonists interact to elicit vasodilation and limit α-adrenergic vasoconstriction in humans. The results of this study highlight the vascular endothelium as a critical site for integration of vasomotor signals in humans. To our knowledge, this is the first study to demonstrate that combined stimulation of the endothelium with ATP and ACh results in enhanced vasodilation compared with combination of either ATP or ACh with an endothelium-independent dilator. Furthermore, we show that ATP and ACh interact to modulate α-adrenergic vasoconstriction in human skeletal muscle in vivo.
血管内皮细胞感知和整合众多输入信号来调节血管张力。最近的证据揭示了内皮细胞内复杂的信号处理,但对于内皮依赖性刺激如何相互作用来调节血流知之甚少。我们假设,与内皮非依赖性扩张剂硝普钠(SNP)与 ATP 或 ACh 的组合相比,用 ATP 和乙酰胆碱(ACh)联合刺激内皮细胞会引起更大的血管舒张,并减轻 α-肾上腺素能血管收缩。我们在年轻成年人(6 名女性,7 名男性)中评估了前臂血管传导率(FVC),在局部动脉内输注 ATP、ACh 或 SNP 单独和以下组合时:ATP+ACh、SNP+ACh 和 ATP+SNP,其中第二个扩张剂在与第一个扩张剂达到稳定状态后共同输注。根据设计,当单独输注时,每个扩张剂都引起相似的反应(ΔFVC,ATP:48±4;ACh:57±6;SNP:53±6 mL·min·100 mmHg;≥0.62)。联合输注内皮依赖性扩张剂引起的血管舒张大于任何一种扩张剂与 SNP 的组合(来自第一个扩张剂的 ΔFVC,ATP+ACh:45±9 与 SNP+ACh:18±7 和 ATP+SNP:26±4 mL·min·100 mmHg, < 0.05)。随后输注苯肾上腺素以评估 α-肾上腺素能血管收缩。与 SNP 相比,在输注 ATP 或 ACh 时,苯肾上腺素引起的血管收缩减少(ΔFVC,-25±3 和-29±4 与-48±3%;<0.05)。当联合输注 ATP+ACh 时,苯肾上腺素的血管收缩反应进一步降低(-13±3%;<0.05 与单独使用 ATP 或 ACh),并且小于当任何一种扩张剂与 SNP 联合时观察到的(SNP+ACh:-26±3%;ATP+SNP:-31±4%;均<0.05 与 ATP+ACh)。我们得出结论,内皮依赖性激动剂相互作用以引起血管舒张并限制人类的 α-肾上腺素能血管收缩。这项研究的结果强调了血管内皮作为人类血管舒缩信号整合的关键部位。据我们所知,这是第一项证明用 ATP 和 ACh 联合刺激内皮细胞会导致血管舒张增强,而不是将 ATP 或 ACh 与内皮非依赖性扩张剂联合使用的研究。此外,我们表明,在体内,ATP 和 ACh 相互作用调节人类骨骼肌中的 α-肾上腺素能血管收缩。